-
1
Dramatic response of advanced pulmonary sarcomatoid carcinoma to tislelizumab combined with anlotinib: a case report
Published 2025-02-01Subjects: Get full text
Article -
2
Tacrolimus and mycophenolate mofetil in corticosteroid-resistant hepatitis secondary to tislelizumab: a case report
Published 2025-02-01Subjects: Get full text
Article -
3
The first case of esophageal mediastinal fistula after immunotherapy for non-small cell lung cancer: case report and literature review
Published 2025-01-01Subjects: Get full text
Article -
4
Clinical Outcomes of Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib and Tislelizumab for Treating Hepatocellular Carcinoma and Type IV Portal Vein Tumor Thrombus
Published 2025-01-01Subjects: “…tislelizumab…”
Get full text
Article -
5
Efficacy and safety of neoadjuvant therapy with tislelizumab plus axitinib for nonmetastatic renal cell carcinoma with inferior vena cava tumor thrombus: a retrospective study
Published 2025-01-01Subjects: “…Tislelizumab…”
Get full text
Article -
6
Case report: A rare case of delayed drug-induced hyponatremia in recurrent upper tract urothelial carcinoma following GC and Tislelizumab treatment
Published 2025-01-01Subjects: Get full text
Article -
7
Case report: Multi-organ injuries induced by tislelizumab
Published 2025-02-01Subjects: Get full text
Article -
8
First-line chemotherapy with tislelizumab for patients with extensive-stage small cell lung cancer: a cost-effectiveness analysis
Published 2024-12-01Subjects: Get full text
Article